These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19729501)

  • 41. Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.
    György B; Fitzpatrick Z; Crommentuijn MH; Mu D; Maguire CA
    Biomaterials; 2014 Aug; 35(26):7598-609. PubMed ID: 24917028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Adeno-Associated Virus 3 Capsid Binding and Neutralizing Antibodies in Healthy and Hemophilia B Individuals from India.
    Daniel HD; Kumar S; Kannangai R; Lakshmi KM; Agbandje-Mckenna M; Coleman K; Srivastava A; Srivastava A; Abraham AM
    Hum Gene Ther; 2021 May; 32(9-10):451-457. PubMed ID: 33207962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficient removal of antibodies to adeno-associated viruses by immunoadsorption.
    Boedecker-Lips S; Judel A; Holtz S; Mayer M; Klimpke P; Kraus D; Schreiner T; Gerstmayer B; Eulitz K; Mayer MC; Weinmann-Menke J
    J Clin Apher; 2023 Oct; 38(5):590-601. PubMed ID: 37415533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.
    Schulz M; Levy DI; Petropoulos CJ; Bashirians G; Winburn I; Mahn M; Somanathan S; Cheng SH; Byrne BJ
    Mol Ther; 2023 Mar; 31(3):616-630. PubMed ID: 36635967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays.
    Gorovits B; Fiscella M; Havert M; Koren E; Long B; Milton M; Purushothama S
    AAPS J; 2020 Jan; 22(2):24. PubMed ID: 31907680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-Based Measurement of Neutralizing Antibodies Against Adeno-Associated Virus (AAV).
    Jungmann A; Müller O; Rapti K
    Methods Mol Biol; 2017; 1521():109-126. PubMed ID: 27910044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
    Leborgne C; Barbon E; Alexander JM; Hanby H; Delignat S; Cohen DM; Collaud F; Muraleetharan S; Lupo D; Silverberg J; Huang K; van Wittengerghe L; Marolleau B; Miranda A; Fabiano A; Daventure V; Beck H; Anguela XM; Ronzitti G; Armour SM; Lacroix-Desmazes S; Mingozzi F
    Nat Med; 2020 Jul; 26(7):1096-1101. PubMed ID: 32483358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An ELISA method for detection of human antibodies to an immunotoxin.
    Benbrook DM
    J Pharmacol Toxicol Methods; 2002; 47(3):169-75. PubMed ID: 12628308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay.
    Krotova K; Aslanidi G
    Hum Gene Ther; 2020 Oct; 31(19-20):1124-1131. PubMed ID: 32495655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-stratified adeno-associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India.
    Daniel HD; Kumar S; Kannangai R; J F; Joel JN; Abraham A; Lakshmi KM; Agbandje-McKenna M; Coleman KE; Srivastava A; Srivastava A; Abraham AM
    J Med Virol; 2022 Sep; 94(9):4542-4547. PubMed ID: 35577570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Prevalence of Antibodies Against Adeno-Associated Virus in Healthy Children and Patients with Mucopolysaccharidosis III: Perspective for AAV-Mediated Gene Therapy.
    Fu H; Meadows AS; Pineda RJ; Kunkler KL; Truxal KV; McBride KL; Flanigan KM; McCarty DM
    Hum Gene Ther Clin Dev; 2017 Dec; 28(4):187-196. PubMed ID: 29064732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Capsid-specific removal of circulating antibodies to adeno-associated virus vectors.
    Bertin B; Veron P; Leborgne C; Deschamps JY; Moullec S; Fromes Y; Collaud F; Boutin S; Latournerie V; van Wittenberghe L; Delache B; Le Grand R; Dereuddre-Bosquet N; Benveniste O; Moullier P; Masurier C; Merten O; Mingozzi F
    Sci Rep; 2020 Jan; 10(1):864. PubMed ID: 31965041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer.
    Smith TJ; Elmore ZC; Fusco RM; Hull JA; Rosales A; Martinez M; Tarantal AF; Asokan A
    Mol Ther; 2024 Jul; 32(7):2080-2093. PubMed ID: 38715362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions.
    Weber T
    Front Immunol; 2021; 12():658399. PubMed ID: 33815421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.
    Rapti K; Louis-Jeune V; Kohlbrenner E; Ishikawa K; Ladage D; Zolotukhin S; Hajjar RJ; Weber T
    Mol Ther; 2012 Jan; 20(1):73-83. PubMed ID: 21915102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell-Based Determination of Neutralizing Antibodies Against Adeno-Associated Virus in Cardiac Gene Therapy.
    Ravichandran AJ; Mazurek R; Ishikawa K
    Methods Mol Biol; 2022; 2573():293-304. PubMed ID: 36040603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme.
    Elmore ZC; Oh DK; Simon KE; Fanous MM; Asokan A
    JCI Insight; 2020 Sep; 5(19):. PubMed ID: 32941184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of anti-adeno-associated virus vector neutralizing antibody titer with an in vitro reporter system.
    Meliani A; Leborgne C; Triffault S; Jeanson-Leh L; Veron P; Mingozzi F
    Hum Gene Ther Methods; 2015 Apr; 26(2):45-53. PubMed ID: 25819687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Goats with low levels of AAV antibody may serve as candidates for large animal gene therapy.
    Pan H; Liu YF; Luo Y; Chen L; Shen B; Song S; Liu M; Wang Z; Wu W; Li M; Zhang Y
    Exp Eye Res; 2023 Aug; 233():109514. PubMed ID: 37207869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay.
    Bass-Stringer S; Thomas CJ; May CN; Gregorevic P; Weeks KL; McMullen JR
    J Vis Exp; 2021 Dec; (178):. PubMed ID: 34958085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.